Sanofi
General ticker "SNYNF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $119.6B (TTM average)
Sanofi does not follow the US Stock Market performance with the rate: -22.2%.
Estimated limits based on current volatility of 1.2%: low 84.57$, high 86.80$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-06, amount 4.84$ (Y5.59%)
- Total employees count: 32436 as of 2002
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [76.26$, 113.81$]
- 2026-12-31 to 2027-12-31 estimated range: [83.88$, 122.74$]
Short-term SNYNF quotes
Long-term SNYNF plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | €46,716.00MM |
| Operating Expenses | €37,119.00MM |
| Operating Income | €9,597.00MM |
| Non-Operating Income | €-3,577.00MM |
| Interest Expense | €626.00MM |
| R&D Expense | €7,842.00MM |
| Income(Loss) | €6,020.00MM |
| Taxes | €1,043.00MM |
| Net Income(Loss)* | €7,813.00MM |
| Stockholders Equity | €71,376.00MM |
| Inventory | €22,691.00MM |
| Assets | €126,806.00MM |
| Operating Cash Flow | €12,132.21MM |
| Capital expenditure | €1,988.55MM |
| Investing Cash Flow | €-2,761.63MM |
| Financing Cash Flow | €-9,262.24MM |
| Earnings Per Share** | €3.20 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are valid for ticker SNY. EPS are Split Adjusted, recent splits may be reflected with a delay.